239 related articles for article (PubMed ID: 18654878)
1. Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease.
Greilberger J; Koidl C; Greilberger M; Lamprecht M; Schroecksnadel K; Leblhuber F; Fuchs D; Oettl K
Free Radic Res; 2008 Jul; 42(7):633-8. PubMed ID: 18654878
[TBL] [Abstract][Full Text] [Related]
2. Carbonyl proteins as a clinical marker in Alzheimer's disease and its relation to tryptophan degradation and immune activation.
Greilberger J; Fuchs D; Leblhuber F; Greilberger M; Wintersteiger R; Tafeit E
Clin Lab; 2010; 56(9-10):441-8. PubMed ID: 21086789
[TBL] [Abstract][Full Text] [Related]
3. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease.
Padurariu M; Ciobica A; Hritcu L; Stoica B; Bild W; Stefanescu C
Neurosci Lett; 2010 Jan; 469(1):6-10. PubMed ID: 19914330
[TBL] [Abstract][Full Text] [Related]
4. Evidence of increased oxidative damage in subjects with mild cognitive impairment.
Keller JN; Schmitt FA; Scheff SW; Ding Q; Chen Q; Butterfield DA; Markesbery WR
Neurology; 2005 Apr; 64(7):1152-6. PubMed ID: 15824339
[TBL] [Abstract][Full Text] [Related]
5. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
Hernanz A; De la Fuente M; Navarro M; Frank A
Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
[TBL] [Abstract][Full Text] [Related]
6. Oxidative LDL modification is increased in vascular dementia and is inversely associated with cognitive performance.
Li L; Willets RS; Polidori MC; Stahl W; Nelles G; Sies H; Griffiths HR
Free Radic Res; 2010 Mar; 44(3):241-8. PubMed ID: 20166891
[TBL] [Abstract][Full Text] [Related]
7. Lipids' peroxidation markers in Alzheimer's disease and vascular dementia.
Gustaw-Rothenberg K; Kowalczuk K; Stryjecka-Zimmer M
Geriatr Gerontol Int; 2010 Apr; 10(2):161-6. PubMed ID: 20446930
[TBL] [Abstract][Full Text] [Related]
8. Malondialdehyde and protein carbonyl as biomarkers for oxidative stress and disease progression in patients with chronic myeloid leukemia.
Ahmad R; Tripathi AK; Tripathi P; Singh S; Singh R; Singh RK
In Vivo; 2008; 22(4):525-8. PubMed ID: 18712183
[TBL] [Abstract][Full Text] [Related]
9. Oxidative damage in mild cognitive impairment and early Alzheimer's disease.
Lovell MA; Markesbery WR
J Neurosci Res; 2007 Nov; 85(14):3036-40. PubMed ID: 17510979
[TBL] [Abstract][Full Text] [Related]
10. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment.
Bermejo P; Martín-Aragón S; Benedí J; Susín C; Felici E; Gil P; Ribera JM; Villar AM
Free Radic Res; 2008 Feb; 42(2):162-70. PubMed ID: 18297609
[TBL] [Abstract][Full Text] [Related]
11. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment.
Markesbery WR; Kryscio RJ; Lovell MA; Morrow JD
Ann Neurol; 2005 Nov; 58(5):730-5. PubMed ID: 16240347
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.
Rodriguez-Oroz MC; Lage PM; Sanchez-Mut J; Lamet I; Pagonabarraga J; Toledo JB; García-Garcia D; Clavero P; Samaranch L; Irurzun C; Matsubara JM; Irigoien J; Bescos E; Kulisevsky J; Pérez-Tur J; Obeso JA
Mov Disord; 2009 Jul; 24(10):1437-44. PubMed ID: 19452554
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine, vitamin B12 and folic acid levels in psoriasis patients.
Cakmak SK; Gül U; Kiliç C; Gönül M; Soylu S; Kiliç A
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):300-3. PubMed ID: 19207655
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment.
Mangialasche F; Polidori MC; Monastero R; Ercolani S; Camarda C; Cecchetti R; Mecocci P
Ageing Res Rev; 2009 Oct; 8(4):285-305. PubMed ID: 19376275
[TBL] [Abstract][Full Text] [Related]
15. Oxidative inactivation of the proteasome in Alzheimer's disease.
Cecarini V; Ding Q; Keller JN
Free Radic Res; 2007 Jun; 41(6):673-80. PubMed ID: 17516240
[TBL] [Abstract][Full Text] [Related]
16. Decreased plasma antioxidants in patients with Alzheimer's disease.
Kim TS; Pae CU; Yoon SJ; Jang WY; Lee NJ; Kim JJ; Lee SJ; Lee C; Paik IH; Lee CU
Int J Geriatr Psychiatry; 2006 Apr; 21(4):344-8. PubMed ID: 16534775
[TBL] [Abstract][Full Text] [Related]
17. Changes in serum carbonyl and malondialdehyde levels following colchicine and vitamin E treatment in Behcet's disease.
Gulbahar O; Adisen H; Koca C; Aricioglu A; Gulekon A
Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):521-4. PubMed ID: 18040527
[TBL] [Abstract][Full Text] [Related]
18. The influence of the serum vitamin C levels on oxidative stress biomarkers in elderly women.
Paniz C; Bairros A; Valentini J; Charão M; Bulcão R; Moro A; Grune T; Garcia SC
Clin Biochem; 2007 Dec; 40(18):1367-72. PubMed ID: 17942089
[TBL] [Abstract][Full Text] [Related]
19. Concentration of malondialdehyde-modified low-density lipoprotein in the jugular bulb during carotid endarterectomy correlates with development of postoperative cognitive impairment.
Saito H; Ogasawara K; Komoribayashi N; Kobayashi M; Inoue T; Otawara Y; Ogawa A
Neurosurgery; 2007 Jun; 60(6):1067-73; discussion 1073-4. PubMed ID: 17538381
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in patients with angiographically defined coronary artery disease.
Mutlu-Türkoğlu U; Akalin Z; Ilhan E; Yilmaz E; Bilge A; Nişanci Y; Uysal M
Clin Biochem; 2005 Dec; 38(12):1059-65. PubMed ID: 16226736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
